Oak Hill Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$691K Hold
2,450
0.13% 86
2025
Q2
$728K Buy
2,450
+40
+2% +$11.3K 0.15% 74
2025
Q1
$751K Sell
2,410
-202
-8% -$59.6K 0.17% 60
2024
Q4
$681K Buy
+2,612
New +$775K 0.16% 66
2024
Q3
Sell
-2,612
Closed -$854K 125
2024
Q2
$816K Buy
+2,612
New +$767K 0.25% 46
2024
Q1
Sell
-2,692
Closed -$788K 117
2023
Q4
$775K Hold
2,692
0.27% 45
2023
Q3
$723K Buy
2,692
+29
+1% +$7.24K 0.28% 43
2023
Q2
$591K Hold
2,663
0.22% 57
2023
Q1
$644K Sell
2,663
-150
-5% -$36.8K 0.25% 55
2022
Q4
$739K Buy
+2,813
New +$754K 0.31% 49

Other funds holding AMGN

Oak Hill Wealth Advisors's AMGN Position: Q3 2025 in Review

Oak Hill Wealth Advisors held its Amgen (AMGN) position steady in Q3 2025 at 2,450 shares worth $691K. The position accounts for 0.13% of the portfolio, ranked #86.

Oak Hill Wealth Advisors first reported a position in AMGN in Q4 2022 and has held it in 10 quarters since. The position peaked at $816K in Q2 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Oak Hill Wealth Advisors held 2,450 shares of Amgen worth $691K as of Q3 2025.
  • Oak Hill Wealth Advisors left its Amgen share count unchanged in Q3 2025.
  • Amgen made up 0.13% of Oak Hill Wealth Advisors's portfolio in Q3 2025, its #86 holding.
  • Oak Hill Wealth Advisors first reported a position in Amgen in Q4 2022 and has held it in 10 quarters since.
  • Oak Hill Wealth Advisors's Amgen position peaked at $816K in Q2 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Oak Hill Wealth Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.